Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H, Wada Y, Kawano Y, Murakami Y, Irie A, Taniguchi K, Kikuchi K, Yamada G, Suzuki K, Honda J, Wilson-Morifuji M, Araki N, Eto M, Baba H, Imamura T.
Nitta H, et al. Among authors: imamura t.
Clin Cancer Res. 2013 Apr 15;19(8):2004-13. doi: 10.1158/1078-0432.CCR-12-1204. Epub 2013 Jan 3.
Clin Cancer Res. 2013.
PMID: 23287562